Skip to content

Clinical trials

Epilepsy trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: China Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20081
20091
20103
20123
20137
20145
20153
20166
20175
20185
20195
20202
20217
202210
20236
20248
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Unknown status30
Recruiting16
Active, not recruiting6
Not yet recruiting4
Enrolling by invitation2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital, Zhejiang University, School of Medicine12
UCB BIOSCIENCES, Inc.5
Xijing Hospital5
Beijing Children's Hospital4
Children's Hospital of Fudan University4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Shanghai Zhongshan Hospital4
Xuanwu Hospital, Beijing4
Eisai Inc.3
Longboard Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy95
Seizures21
Epilepsies, Myoclonic4
Lennox Gastaut Syndrome4
Tuberous Sclerosis4
Neurodevelopmental Disorders3
Alzheimer Disease2
Autoimmune Diseases of the Nervous System2
Brain Diseases2
Brain Injuries, Traumatic2

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.